Abstract
Methylphenidate (MPH) is the most commonly prescribed treatment for attention-deficit/hyperactivity disorder (ADHD). The therapeutic mechanisms of MPH are not, however, fully understood. We studied the effects of MPH on brain activity in male children and adolescents with ADHD, using the blood flow radiotracer technetium-99m ethyl cysteinate dimer (99mTc-ECD) and single-photon emission tomography (SPET) . The study was randomized, double blind, and placebo controlled (MPH group, n=19; placebo group, n=17), Radiotracer was administered during the performance of the Continuous Performance Test and before and after 4 days of MPH treatment. Statistical parametric mapping (SPM99) analysis showed a significant reduction in regional cerebral blood flow in the left parietal region in the MPH group compared with the placebo group (P<0.05, corrected for multiple comparisons). Our findings suggest that the posterior attentional system, which includes the parietal cortex, may have a role in the mediation of the therapeutic effects of MPH in ADHD.
References
Zarin DA, Suarez AP, Pincus HA, Kupersanin E, Zito JM. Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice. J Am Acad Child Adolesc Psychiatry 1998; 37:1262–1270.
Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM. [3H]Threo (±)-methylphenidate binding to 3,4-dihydrophenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 1985; 45:1062–1070.
Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine tranporter before and after methylphenidate treatment. Eur J Nucl Med 2000; 27:1518–1524.
Kim BN, Lee JS, Cho SC, Lee DS. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 2001; 42:19–29.
Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JDE. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 1998; 95:14494–14499.
Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, Zametkin AJ. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 1993; 8:377–386.
Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in human brain. J Neurosci 2000; 20:1–6.
Volkow N, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding YS, Gatley SJ, Gifford A, Franceschi D. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21:1–5.
Volkow N, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 2002; 43:181–187.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994:78–85.
Conners CK. Continuous performance test [computer program]. Kensington: Behavior Medicine Inc., 1980
Acton PD, Friston KJ. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med 1998; 25:663–667.
Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285:107–110.
American Academy of Child and Adolescent Psychiatry. Practice Parameters for Psychiatric Assessment of Children and Adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36 :85S–121S.
Morecraft RJ, Geula C, Mesulam M. Architecture of connectivity within a cingulo-fronto-parietal neurocognitive network for directed attention. Arch Neurol 1993; 50:279–284.
Levy F, Farrow M. Working memory in ADHD: prefrontal/parietal connections. Curr Drug Targets 2001; 2:347–352.
This study was supported by FAPERGS, NOVARTIS, and FIPE-HCPA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Szobot, C.M., Ketzer, C., Cunha, R.D. et al. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med 30, 423–426 (2003). https://doi.org/10.1007/s00259-002-1082-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-002-1082-0